CSat Investment Advisory’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-55
Closed -$5K 1011
2020
Q3
$5K Buy
55
+6
+12% +$545 ﹤0.01% 1086
2020
Q2
$8K Buy
+49
New +$8K ﹤0.01% 1076